Ur-Energy

Phase A — Understand the business

Company Overview

Ur-Energy Inc. is a Wyoming-focused in-situ recovery (ISR) uranium miner, incorporated in Canada (continued under the Canada Business Corporations Act, 2006; originally Ontario, 2004), HQ Casper, WY. Dual-listed: URG (NYSE American), URE (TSX). It is classified by the SEC as an "exploration stage issuer" — it has no proven or probable reserves (it has never filed a feasibility study and has no plans to, given ISR economics), so it expenses pre-production development rather than capitalizing it. This accounting status is structural and material: it inflates reported operating losses versus a "production-stage" peer.

What it sells: triuranium octoxide (U3O8 / "yellowcake," 70–90% U3O8 by weight), delivered to a third-party conversion facility and sold to nuclear utilities under multi-year term contracts.

Two material assets, both Wyoming ISR:

• Lost Creek (Sweetwater County, Great Divide Basin) — the flagship, operating since 2013. Licensed plant capacity up to 2.2M lbs U3O8/yr (of which up to 1.2M lbs/yr may be produced from Lost Creek wellfields); designed run-rate ~1M lbs/yr. The only source of produced/sold U3O8 in the company's history. 3.475M lbs produced cumulatively through 12/31/2025 from the HJ horizon.
• Shirley Basin (Carbon County) — the "second flagship," acquired via Pathfinder (2013). Licensed wellfield capacity 1M lbs U3O8/yr. A satellite plant (loaded resin shipped to Lost Creek for finishing). Commenced mining operations in April 2026 — the single most important recent event.

Contract structure (the crux): multi-year term agreements with 8 customers (the 10-KForm 10-KA company’s audited annual report to the US regulator. The most complete thing it publishes. says eight; the Q1 10-QForm 10-QThe quarterly version of the annual report. Lighter, and not audited. references six customers for the 2026 delivery schedule) — leading nuclear companies. Base annual deliveries of 100,000 to 1.4M lbs U3O8 from 2026 through 2033; combined base deliveries 2026–2033 total 5.75M lbs. Prices escalate annually from initial pricing and are "anticipated to be profitable on an all-in production cost basis." Critically, the bulk were struck in 2022–23 when the long-term price was $43–57/lb — far below today's ~$93 term price.

The plain-terms model: dig uranium cheaply via ISR (no tailings, low surface disturbance), sell it under long contracts to utilities, and live or die on (a) whether production ramps to fill those contracts and (b) whether the contract book reprices toward spot before the balance sheet runs out of runwayRunwayHow long the cash lasts at the current rate of spending. It shortens the moment spending rises, which is why a figure taken from a quiet quarter flatters..

Supply Chain

Map upstream → company → end customer, named where the filings name them:

Upstream inputs: Groundwater (the lixiviant base, fortified with oxygen + CO2 + sodium bicarbonate), drilling/wellfield equipment (header houses fabricated at the company's own Casper construction shop), ion-exchange resin, reverse-osmosis systems. 15 drill rigs at Lost Creek, 8 at Shirley Basin. Inflation/equipment-availability flagged as an ongoing risk.

The company (mid-stream): Lost Creek processing plant is full-cycle — capture (IX), elution, precipitation, filter press, drying, drumming. This is a genuine structural advantage over capture-only ISR peers who must contract finishing out. Shirley Basin is capture-only (resin trucked ~to Lost Creek for finishing).

Critical downstream chokepoint — the conversion facility: Drummed yellowcake is trucked to a third-party conversion facility (the filings do not name it; in the U.S. uranium chain this is Honeywell/ConverDyn's Metropolis, IL plant or Canadian/foreign converters ). Inventory is held at the converter — at 3/31/2026, 417,231 lbs at the conversion facility (incl. 240,000 purchased pounds). This is a single named node the company does not control; it is the bottleneck between production and revenue recognition (sale recognized when product transfers to purchaser at the converter).

End customers: U.S. (and the 10-K says "global") nuclear utilities, undisclosed by name. Past disclosed buyer: U.S. DOE / NNSA (100,000 lbs sold Jan 2023 into the national uranium reserve).

Counterparty in the inventory loan: an unnamed lender from whom URG borrowed 250,000 lbs of U3O8 (a second 150,000-lb facility is undrawn) — a financing/supply node, due Nov 30 2026.

Single-source dependencies: the conversion facility (one node), and — structurally — the entire revenue line depends on two Wyoming wellfields. our figures/supply-chain.md are empty, so the above is filing-derived; names beyond the converter are not disclosed.

Competitive Advantages (moats)

For a commodity producer the "moat" is position on the cost curve + permits + jurisdiction, not brand. Ur-Energy's durable advantages:

1. Permitted, operating, full-cycle ISR in Wyoming — the highest-value scarcity. Permits are the true moat in U.S. uranium: Lost Creek has been fully licensed since 2012; Shirley Basin received all major federal/state authorizations (NRC source-material license, WDEQ permit-to-mine, BLM ROD) years ago and is now in production. New entrants face a decade-plus permitting gauntlet (NRC + BLM + WDEQ + EPA aquifer exemption + sage-grouse core-area constraints). This is a real, time-based barrier.
2. Low ISR cash cost. Produced cash cost ~$33.67/lb in Q1 2026 (ex-tax), produced cost/lb sold $48.85; against an ~$85 spot and ~$93 term, the unlevered economics are attractive — when selling at market. Recovery exceeds the 80% industry standard.
3. Spare processing capacity as an optionality moat. Lost Creek's 2.2M-lb licensed plant capacity (vs. ~1M-lb design run-rate) can toll-process Shirley Basin and, potentially, Lost Soldier or third-party ore — a scale/utilization lever peers without a full plant lack.
4. U.S.-domestic, non-Russian, non-Kazakh supply in a market where provenance is now a policy variable (see Lens 10). This is the macro moat: a Western utility de-risking its fuel chain structurally prefers a Wyoming pound.

Bargaining power: Weak-to-moderate over customers (utilities are large, sophisticated, and URG needs the contracts to fund the ramp — evidenced by the 2022–23 contracts locked well below today's price). Moderate over suppliers (it builds its own header houses; commoditized inputs). The single most damning moat fact is in the numbers: a genuine cost-curve advantage was given away by contracting forward at $43–57/lb — the moat exists at the asset level but was not captured at the contract level. positioning.md/bottlenecks.md are empty; assessment is filing + market derived.

Segments

The company operates as a single reportable segment (uranium; all revenue and long-lived assets in the U.S.) — explicitly stated in the Q1 2026 10-Q. our figures is empty, consistent with this. There is therefore no product/geographic segmentation to break out. The only meaningful "mix" is produced vs. non-produced (purchased/borrowed) pounds, which drives margin:

The trend is improving and accelerating: produced-pound mix rose from 47% (2024) to 75% (2025) of sales, dragging blended cost down $8.82/lb and flipping per-pound economics from a $6.19 loss to a $6.25 profit. The cause: the Lost Creek ramp (pounds captured +40%, drummed +65% YoY in 2025) lowering unit cost, plus the painful 2024 non-produced pounds (bought/borrowed at $75.87/lb to meet a 2024 contract) washing out.

---

Phase B — Measure performance

Earnings Result (latest print: Q1 2026, filed 2026-05-08)

The headline is a study in why this name confuses screens.

Income statement (Q1 2026 vs. Q1 2025), $000:

• Sales $3,931 (vs. $0 in Q1'25 — no deliveries that quarter)
• Cost of sales $(2,687); gross profit $1,244 (vs. $(2,598) loss)
• Operating costs $(21,577) — of which Development $14,946 + E&E $2,279 + G&A $3,923 + ARO accretion $429
• Operating loss $(20,333) (vs. $(15,835))
• Interest income $765; interest expense $(2,946); MTM loss $(6,363); FX $(639); other $741
• Net loss $(28,775) vs. $(10,898) — the loss nearly tripled

Why the loss widened despite the first profitable-looking quarter: three non-operating items — (1) $(6.4)M mark-to-market loss on the conversion-option derivative + capped call + inventory loan; (2) $(2.9)M interest expense (the new convertible); (3) a step-up in development expense ($14.9M, +53% YoY) as Shirley Basin construction/development hit full stride. The operating business actually improved (the 55,000 produced lbs sold at $70.98/lb carried $22.13/lb profit, a 31.2% margin — the best in the dataset). The screen-ugly net loss is an artifact of (a) expensing development, (b) derivative accounting on the convertible, and (c) lumpy deliveries (only 55,000 of the year's 1.3M lbs landed in Q1).

The $70.98/lb tell: Q1 deliveries came from 2024-negotiated contracts with a market-based pricing component — proof that newer contracts capture spot, and the realized price marches up as old contracts roll off.

2026 guidance (management): sell 1,300,000 lbs at ~$63/lb avg ≈ ~$82M revenue; vs. the 10-K's "up to $82.9M from up to 1.3M lbs." Of the 1.3M lbs, only 210,000 lbs are 2024-vintage (market-linked); 1,090,000 lbs are 2022–23 base-escalated at $43–57/lb — hence the blended ~$63 despite an $87 spot. Delivery cadence is brutally back-loaded: 55K (Q1, done) / 215K (Q2) / 190K (Q3) / 840K (Q4). The Q4 cliff is the single biggest execution risk of the year.

Balance-sheet flags:

• Cash $122.8M + restricted $12.9M = $135.7M at 3/31/2026 (flat sequentially — the convertible + warrant exercises funded the burn).
• No trade receivables; inventory $28.0M; 417,231 lbs at the converter (incl. 240K purchased).
• Long-term debt $67.6M (net carrying; $120M face convertible) + conversion-option derivative $56.2M + inventory derivative obligation $17.3M + ARO $44.5M. Shareholders' equity $82.9M; accumulated deficit $407.8M.
• FY2025 operating cash flow $(43.1)M; investing $(23.6)M; financing +$114.9M (convertible $120M gross + ATM $16M + warrants). Net cash burn before financing ~$67M in 2025.

Market reaction / what's priced: Stock ~$1.35–1.49 (Q1'26) vs. a 52-wk that has been materially higher; near lows even as spot/term hit multi-year/18-year highs. The market is pricing execution risk and dilutionDilutionIssuing new shares, so each existing share owns a smaller slice of the same company., not the commodity.

Earnings Calls (sentiment trend)

transcripts/ is empty (no transcript ingested; Fool/Insider-Monkey coverage of a micro-cap is thin). Sentiment is reconstructed from the filings' MD&A "Looking Ahead" prose + secondary coverage.

• Tone, last ~3 prints: measured-constructive, increasingly operational. FY2025 10-K: "2026 will be a pivotal year… commence operations and production at Shirley Basin." Q1'26 10-Q: confirms Shirley Basin began mining in April 2026, "uranium-bearing solution is now being captured," resin-to-Lost-Creek shipments "expected summer 2026".
• What management keeps saying: "ramp up," "increase production rates and flow rates," "profit per pound," "remain a leading U.S. uranium producer," "safe and compliant." A repeated, candid admission of "remaining operational challenges associated with our ramp-up" at Lost Creek — they are not over-promising the ramp.
• What they stopped saying: the 2022–24 narrative of distress/standby ("nominal production," "persistent poor market conditions") is gone, replaced by a build-and-deliver narrative.
• Globe & Mail coverage explicitly framed the Q1 call as "Ramp-Up and Risks" — secondary sources read the same tension this dossier flags.

The honest read: management's tone is credible and not promotional, but the calls are dominated by operational ramp commentary, not a triumphant earnings story — appropriate for a company still in the build phase.

Comps

Peers are not yet tracked in _index.json (only Ur-Energy itself), so the table is web-sourced with dates; multiples that cannot be sourced are marked n/a rather than fabricated.

EV/Sales and EV/EBIT are n/a across the small-caps (consensus forward revenue for each not pulled; and on FY2025 actuals these names trade at absurd multiples on trough revenue, which is meaningless mid-ramp). Two honest observations: (1) URG is an order of magnitude smaller than UEC/UUUU and ~5.5x smaller than DNN — it is the sub-scale name in the U.S. producer cohort; (2) the peer-relative setup is that Cameco trades on ~100x earnings — the whole sector is priced on future term-price realization, not current cash flow, which is precisely the lens through which URG must be valued. 5-year avg ROE is n/a for URG (persistent losses; negative ROE) and not sourced for peers.

Stock-Price Catalysts (what moves URG >5%)

Pattern over recent years:

• The uranium spot/term price is the dominant driver. URG is a high-beta proxy on U3O8. The late-2025 spike (spot >$101 in Jan 2026) and the 18-year-high term price ($93, Mar 2026) are the macro backdrop; the Q2'26 consolidation to $84–87 mirrors the stock's drift to lows.
• Financing events move it the wrong way. The 2023 ($46.1M) and 2024 ($69M) equity raises and the Dec-2025 $120M convertible are dilutive/overhang catalysts; warrant exercises (38.3M warrants exercised post-12/31/2025 at $1.50) add float.
• Shirley Basin milestones — permits, construction completion, and the April 2026 production start — are de-risking catalysts.
• Policy catalysts — Russian-import ban, DOE funding, any U.S. strategic-reserve buying — are sector-wide up-catalysts (see Lens 10).
• Delivery execution — the Q4'26 840K-lb delivery is a binary print-shaped catalyst.

The market reaction tells you what it cares about: the commodity and dilution dominate; operational beats have not (yet) re-rated the stock, which is the contrarian setup — production is arriving as the multiple compresses.

---

Phase C — Judge people & books

Management

• CEO: Matthew D. Gili (since Dec 13, 2025). Professional engineer; President of Ur-Energy since June 2025; prior President & COO of i-80 Gold (2021–25) and CEO of Nevada Copper (2018–20). Red/yellow flag worth noting: Nevada Copper filed for bankruptcy (2024, after his tenure) and i-80 Gold has had a turbulent operational/financing history — Gili's pedigree is operational mining leadership, but not an unblemished value-creation record. New to the seat (<7 months at this dossier's date).
• Chairman: John W. Cash — with Ur-Energy since 2007, CEO 2022–Dec 2025; stepped up to Chairman + strategic advisor. Continuity preserved; he ran the 2022 ramp-restart decision.
• CFO: Roger L. Smith (long-tenured, since 2008-era employment agreement). Note also recent senior-team contract activity (Schierman, Walle, Ritchie employment agreements dated Nov–Dec 2025), consistent with a leadership refresh around the Gili transition.
• Skin in the game / insider ownership: our figures not present; Part III (ownership/comp) is incorporated by reference to the 2026 proxy, not in the 10-K — so insider ownership is n/a. No Rule 10b5-1Rule 10b5-1 planA schedule an insider sets in advance saying when their shares will be sold, so the sales cannot be timed on private news. A sale made OUTSIDE such a plan is a live decision, which is why it carries more information. plans were adopted/terminated in Q4'25.
• Capital-allocation history: This is the crux of the management judgment. (1) The 2022 decision to ramp Lost Creek back to commercial production was correctly timed ahead of the uranium bull run — a good call. (2) But the contracting decisions — locking 2022–23 term deliveries at $43–57/lb — meant the company sold its 2026–28 production well below the eventual spot, capturing the volume but not the price. (3) Financing has leaned heavily on dilution (share count 270.9M end-2023 → 397.3M Apr-2026, ~+47%) plus a structurally expensive convertible (18.6% effective rate — see Lens 10). ROE has been persistently negative (accumulated deficit $407.8M). The pattern: operationally competent, commercially sub-optimal on price, and shareholder-dilutive on funding.
• Founder vs. professional manager: Professional managers throughout — no founder/owner-operator with concentrated equity. Implies less owner-mindset discipline on dilution; consistent with the funding history.

Forensic Red Flags

Forensic-analyst pass across the three statements:

• Revenue recognition: Clean and conservative — recognized on transfer to purchaser at the converter; lumpy by design (a handful of deliveries/year). Q1'26 $3.9M is a real sale, not channel-stuffing. Low risk.
• The convertible-note accounting is the dominant red flag — though disclosed, not improper. Because URG's functional currency is the Canadian dollar while the notes' conversion price ($1.73) is USD-denominated, US GAAP forces the embedded conversion option to be bifurcated as a stand-alone derivative. Result: a $120M face note carries at only $67.6M net (after a $52.3M conversion-option-derivative discount + issuance costs), and the effective interest rate is 18.6%. That is venture-debt-grade cost of capital on paper that nominally pays 4.75%. Every quarter, debt-discount amortization ($1.5M in Q1'26) plus MTM swings on the derivative ($(3.9)M in Q1'26) flow through the P&L — non-cash, but they make the company look far worse and introduce earnings volatility entirely unrelated to operations. This is the #1 thing a screen will misread.
• MTM derivative complexity: Four separate derivatives on the balance sheet (conversion option, capped call, warrant liability, inventory-loan obligation), three requiring Level 2/3 fair-value models with subjective volatility inputs. BDO flagged the convertible/derivative valuation as a Critical Audit Matter. Not fraud — but a genuine "hard to model, easy to misjudge" zone.
• Inventory & NRV: NRV write-downs were a recurring drag ($6.0M in 2024, $2.7M in 2025) when carrying cost exceeded spot — they have shrunk as production cost fell and spot rose, and "largely stopped in 2H 2025." Watch inventory-cost vs. spot if uranium rolls over. Conversion inventory cost/lb $63.07 (produced+non-produced blend) at YE'25 vs. ~$86 spot — currently above water.
• Cash flow vs. earnings: No divergence concern of the "earnings>cash" kind — the opposite. Net loss is worse than cash burn because of non-cash derivative/discount items. Operating cash burnCash burnHow much more cash goes out than comes in, per period. The clock on a company with no profits. ($43.1M FY25) is real and funded by financing.
• SBC: Modest ($1.9M FY25) — not flattering non-GAAP (the company doesn't lean on adjusted metrics).
• ARO: $44.5M asset-retirement obligation (growing with wellfield expansion) — appropriate for ISR groundwater restoration; $50.4M of surety bonds collateralized by restricted cash. Adequately reserved/bonded.
• Going concern: No going-concern qualification; BDO issued a clean opinion; management asserted effective internal controls (no 404(b) auditor attestation — smaller reporting company).
• PFIC status: Expects to be classified a Passive Foreign Investment Company — a tax drag for U.S. holders, not an accounting red flag.

Regulatory findings (required sub-section) — read regulatory/regulatory-findings.md:

• SEC Litigation Releases: None for Ur-Energy (EDGAR EFTS LR search, 2021–2026).
• SEC AAERs: None.
• Item 3 Legal Proceedings (FY2025 10-K): "None." Operations not subject to MSHA (Mine Act) regulation.
• Non-SEC enforcement (web): No material FTC/DOJ/EPA enforcement actions, consent decrees, fines, or penalties surfaced against Ur-Energy in web search. The company operates under heavy NRC/WDEQ/BLM/EPA licensing oversight, but that is routine permitting, not enforcement.
• Conclusion: No material regulatory or legal findings — verified via SEC EDGAR EFTS (LR, AAER), web search, and 10-K Item 3 as of 2026-06-30.

The books are clean but complex. The forensic risk is not fraud — it's that the convertible's derivative accounting makes the equity look more impaired than the cash reality, while the 18.6% effective cost is a real economic burden.

---

Phase D — Project & stress-test

Forward Projection (EPS, next three fiscal years: FY2026 / FY2027 / FY2028)

Built bottom-up from FY2025 actuals + 2026 guidance. URG is loss-making and accounting-noisy; per-pound operating economics are the honest signal, so I project operating profit/(loss) and EPS with explicit inputs. Share count base ~397.3M, creeping to ~410M+ on warrant/option dilution.

Shared inputs:

• 2026 deliveries 1.3M lbs @ ~$63/lb = ~$82M revenue.
• Produced cost ~$49–53/lb, falling toward high-$40s as Lost Creek ramps + Shirley Basin matures (early Shirley Basin lbs cost more until rates rise).
• Development expense stays elevated in 2026 (~$50–60M run-rate annualized off Q1's $14.9M) then steps down in 2027+ as Shirley Basin development costs convert to capitalized/production costs.
• Convertible: ~$2.9M/qtr interest+amortization, plus unpredictable MTM. ~$135.7M cash.

Inputs labeled; arithmetic shown for base FY2028: 1.2M lbs sold × ($72/lb realized − ~$50/lb cost) = ~$26M gross profit; less ~$45M normalized operating costs (E&E+G&A+lower development) = ~$(19)M operating; less ~$12M net financing = ~$(31)M... which does not reach breakeven on this arithmetic. The honest conclusion: GAAP breakeven likely requires either (a) materially higher realized prices as the legacy book rolls off post-2028, or (b) a step-change in volume well above 1.2M lbs, or (c) reclassification benefits as development spend ends. The "near breakeven" base case above is generous; a stricter read keeps URG loss-making through 2028 on legacy-contract pricing. The EPS line is the wrong lens for 2026–28 — the right lens is: does production ramp on schedule, and does the contract book reprice toward spot in 2028–2033?

Forecast log (per skill, the --watchlist loop SKIPS our model create) — not logged. The trackable base call, were one logged: "URG FY2027 reported net loss per share narrower than $(0.10)" — p≈0.6, resolves 2027-12-31, tags ur-energy,deep-dive. (Recorded here for the analyst; not committed to the tracker in unattended breadth mode.)

Bull vs Bear

Bull case. Ur-Energy is one of only a handful of permitted, operating, full-cycle U.S. ISR uranium producers at the exact moment the West is structurally re-shoring nuclear fuel. The asset-level economics are genuinely good (cash cost ~$34/lb vs. ~$85 spot / ~$93 term). Two mines now in production (Shirley Basin de-risked April 2026) double the production base into a 1.5–2M-lb combined capacity envelope. The legacy $43–57/lb contracts roll off through 2030; every new ton reprices toward a term price at an 18-year high, and the Q1'26 $70.98/lb realization already proves market-linked contracts capture it. The contract book (5.75M lbs base 2026–2033) provides revenue visibility unusual for a junior. Demand tailwinds — AI/data-center power, government pro-nuclear policy, the Russian-import ban funneling utilities toward domestic pounds, $2.7B DOE enrichment funding — are secular, not cyclical. The stock sits near lows while the commodity sits near highs: the operating leverage is in front of you, unpriced.

Bear case (3 risks that could permanently impair or structurally cap the equity):

1. The convertible + dilution death-by-a-thousand-cuts. A $120M note with an 18.6% effective rate, conversion at $1.73 (the stock is below that at ~$1.35–1.49), plus a serial-ATM/warrant dilution machine (+47% shares since 2023). If the ramp consumes cash longer than planned, URG funds it the only way it ever has — by issuing equity into a low stock price — permanently impairing per-share value even if the business succeeds.
2. Execution risk on a back-loaded delivery year. 840,000 of 2026's 1.3M lbs must deliver in Q4, off two ramping mines, one of which (Shirley Basin) only started in April and won't ship finished product until summer. Any ramp slip + the inventory-loan return (250K lbs due Nov 30, 2026) forces spot purchases at ~$85+ to honor $43–57/lb contracts — i.e., selling at a loss to meet commitments, exactly the 2024 mistake (which cost $20.87/lb on borrowed pounds).
3. Commodity reversal. URG is a high-beta uranium proxy. Spot already round-tripped from >$101 (Jan'26) to ~$85 (Q2'26). A demand air-pocket or a supply response (Kazatomprom, restarts, secondary supply) that pulls spot back to the $50s would simultaneously gut the equity, trigger NRV write-downs, and remove the entire re-rating thesis.

Pre-mortem (it's late 2027, the thesis broke — what happened?): Shirley Basin's ramp stalled on wellfield/flow-rate issues (the same class of "operational challenges" management already flags at Lost Creek); to honor 2026–27 contracts URG bought spot at $80+ and sold at $50, posting losses; cash dwindled below comfort; it issued equity at $1.10 and tapped the convertible's overhang; spot drifted to $65 as the AI-power narrative cooled; the stock halved. The business survived; the equity didn't compound.

Are multiples too high? On current cash flow, every uranium name (Cameco at ~100x) is "too high" — the sector is a forward-term-price option. URG specifically is too small and too loss-making to value on multiples; it's an option on (ramp execution × term-price realization × non-dilution). The option has real value but a wide outcome distribution.

Contrarian view (what the market refuses to see): The market is treating URG as a perpetually-dilutive cash-burner near its lows — yet it has just doubled its production base and is one repricing cycle away from selling 1.5M+ lbs/yr at $75–90 instead of $50. The thing the bears under-weight: the contract book is a rolling repricing engine, and the 2024-vintage market-linked tons ($70.98/lb) are a preview of 2028+. The thing the bulls under-weight: that repricing is years out, and the convertible can impair the equity before it arrives.

Devil's Advocate (short-seller)

Dismantling the bull case:

• The "low cash cost" is a half-truth for equity holders. Yes, cash cost is ~$34/lb. But URG is an exploration-stage issuer that expenses all development — the real, all-in cost of putting a pound in a drum (including the $55M+/yr development spend and $120M of Shirley Basin capexCapital expenditureMoney spent on long-lived things — buildings, machines, servers — rather than on running costs.) is far higher than the $/lb cash cost suggests. The company has lost money every year; accumulated deficit is $407.8M against $82.9M of equity. "Low cost" hasn't produced a single profitable year.
• Revenue is concentrated in a handful of contracts at below-market prices, with the volume back-loaded. 1.09M of 1.3M lbs in 2026 are locked at $43–57/lb while it costs ~$50/lb to produce — the company is contractually obligated to sell some 2026 pounds at roughly cost or a loss while spot is $85. The bull "operating leverage" is structurally deferred to 2028+, and the bears get to watch dilution in the meantime.
• The most dangerous fact bulls underestimate: the conversion price is above the stock. $1.73 conversion vs. ~$1.35–1.49 market = the convertible is out of the money, so it behaves like 18.6%-effective-rate straight debt, and if the stock stays here the note must be refinanced/repaid in cash (Jan 2031) — another funding event. The capped call (floor $1.73 / ceiling $2.72) only helps if the stock rises.
• Worst capital-allocation moves: selling 2026–28 production forward at $43–57/lb (giving away the bull market), and funding via a Canadian-functional-currency USD convertible that triggers punitive bifurcation accounting and an 18.6% effective rate. Both are self-inflicted.
• Most dangerous competitor bulls underestimate: not another junior — it's secondary supply + Kazatomprom. URG is a marginal U.S. producer; the global cost curve is set by Kazakh ISR at far lower cost. If Kazatomprom de-stocks or restarts idled capacity, spot falls and URG's entire thesis (and its NRV) goes with it. Domestically, UEC (10x the size, $488M cash, no debt) can out-wait and out-fund URG in any downturn.
• What must hold for today's price: that both mines ramp on schedule, the contract book reprices up before cash runs low, spot holds $80+, and no further large dilution. That's four things, each uncertain.
• Growth disappoints by 20–30%: if 2026 deliveries come in at ~0.9–1.0M lbs instead of 1.3M (a plausible Shirley-Basin-ramp miss), revenue is ~$60M not $82M, the cash burn extends, and a dilutive raise near lows becomes likely — directly impairing per-share value.
• Single permanent-impairment scenario: a multi-year uranium price collapse to the $50s (supply response + demand pause) while URG is mid-ramp and cash-light — forcing equity issuance at distressed prices and NRV write-downs. Plausibility: moderate (it's a cyclical commodity; it round-tripped $101→$85 in five months already).

Management Questions (15, ordered by information value)

1. Of the 1.3M lbs guided for 2026, how many are at below current production cost, and what is the dollar P&L on the legacy $43–57/lb contracts vs. cost — i.e., are you delivering some 2026 pounds at a loss?
2. Walk through the Q4 2026 cadence: what gives you confidence in delivering 840,000 lbs in a single quarter off two ramping mines, and what is the contingency if Shirley Basin or Lost Creek under-produces?
3. The inventory loan (250K lbs) is due Nov 30, 2026. Do you return produced pounds or buy spot? At ~$85 spot, what's the net cost, and could you be forced to buy high to deliver low?
4. The convertible's effective interest rate is 18.6% and the conversion price ($1.73) is above the stock. What is the refinancing/repayment plan for January 2031, and under what stock price does it convert vs. require cash?
5. What is the realistic steady-state combined production run-rate (Lost Creek + Shirley Basin) and in which year do you reach it — 1.3M? 1.5M? 2M lbs/yr?
6. What is your contracting strategy for 2028–2033 deliveries — what share will be market-linked vs. fixed-escalated, and at what floor/ceiling are you willing to lock new tons given a $93 term price?
7. At what uranium price do you stop expensing as exploration-stage and consider establishing reserves / capitalizing development — and would you ever reclassify to a production-stage issuer to normalize reported earnings?
8. What is the path to your first full year of positive operating cash flow, and what production + price combination does it require?
9. CEO transition: Mr. Gili, given Nevada Copper's outcome and i-80 Gold's challenges, what specifically will you do differently in capital allocation and operational execution at Ur-Energy?
10. What are the remaining "operational challenges" at the Lost Creek ramp (flow rates, wastewater), and what does the $25M wastewater-treatment facility (2026 H2–2027) actually unlock in incremental pounds?
11. How dependent is the model on the single third-party conversion facility, and what is your exposure if conversion capacity tightens or pricing rises?
12. Do you intend further ATM equity issuance in 2026–27, and at what stock price would you refuse to issue?
13. What is the capital and timeline to bring LC East / Lost Soldier / the Adjoining Projects into production, and how do they compete for capital against Shirley Basin optimization?
14. How do you think about the threat of low-cost Kazakh ISR supply and secondary-market de-stocking to your realized prices over the next 3–5 years?
15. What use, if any, will you make of the spare 2.2M-lb Lost Creek plant capacity — toll processing for third parties, and what would that contribute?

---